1 / 27

Types of injections covered

Types of injections covered. IM intramuscular IV intravenous (only difficult one that requires more training) intralesional subcutaneous subconjunctival sub- Tenon’s. Most common indications for injections in optometry. IV fluoroescein angiography diabetic retinopathy ARMD

sofia
Télécharger la présentation

Types of injections covered

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Types of injections covered • IM intramuscular • IV intravenous (only difficult one that requires more training) • intralesional • subcutaneous • subconjunctival • sub-Tenon’s

  2. Most common indications for injections in optometry • IV • fluoroescein angiography • diabetic retinopathy • ARMD • intralesional (most common) • chalazion • Kenalog® (triamcinolone) 40 • 0.1 to 0.3cc injected • subconjunctival • inflammation • IM • to be prepared in the event anaphylactic shock occurs when doing FLAN • epinephrine 1000:1 injected IM

  3. Injectibles billing • FLAN  92235 with ACLS and crash cart • subcutaneous or IM  90782 therapeutic or diagnostic; NOT for cosmesis • intralesional injection for chalazia 11900

  4. Effective infection control • Assume EVERY patient is positive for HIV, HBV, HCV, TB. Take all reasonable precautions to protect yourself, staff from infection. • OSHA requires exposure control plan, etc.

  5. Considerations for bloodborne pathogen controls • (Main) needle stick injuries • sharp container close to location where sharp used • new sharps that reduce possibility of needle stick injuries. • mucous membrane contact • non-intact skin contact • wash hands & wear gloves during injection procedures.

  6. “bottom line for ODs performing injections” • OSHA • Exposure Control Plan • Bloodborne pathogen controls • “get your act together” • review & update annually

  7. Speed of onset for injections (fastest first) • IV • IM (“almost” as quick as IM) • subcutaeous

  8. Considerations when performing fluoroescein angiography • anaphylaxis to IV NaFl • Type I hypersensitivity • IMMEDIATE • May avoid by taking a great history • asthma • allergy • atopic

  9. signs & symptoms to IV NaFl anaphylaxis • *BOARDS* • cutaneous: • hives • itching • angioedema • respiratory • wheezing • tachypnea • cyanosis • tightness in throat • shortness of breath • When above present: • activate EMS • administer EPI pen (1/1000 epinephrine IM) • IM diphenhydraminemay be used for urticaria (hives), itching • monitor vitals  ABC’s of CPR  supplemental oxygen ifs needed • Trendelenberg position

  10. Anaphylaxis to IV NaFl (Dr. Landgraf’s mnemonic) • SCREAM • S: signs & symptoms of anaphylaxis: • C: cutaneous • urticaria, itch • R: respiratory • wheezing, tachypnea, cyanosis, tightness in throat, shortness of breath • E: EMS activation • call 911 • A: anaphylaxis kit or epi-pen • 1000:1 epinephrine IM; possibly diphenhydramine IM • M: monitor vitals • CPR, supplemental oxygen, Trendelenberg position

  11. General principals about needles for injections • diameter and length • diameter: • size given as “gauge”: • smaller gage  larger diameter • larger gage  smaller diameter • length: • length varies for purpose: • subcutaneous < intralesional < IM < IV • IM closer to 20 gauge; longer needle • Eye closer to 30 gauge; shorter needle

  12. General principles about syringes • available in different sizes • TB syringe == 1 cc • 3cc, 5cc, 10cc

  13. Main reasons OD would perform IM injection • anaphylaxis to IV NaFl • IM diphenhydramine (Benadryl®) • IM epinephrine (1000:1) • pre or post FLAN for nausea and vomiting • IM phenergan or Compazine • nausea associated with acute angle closure glaucoma • IM phenergan or Compazine • Used for irritating medications • Used for larger volumes (up to 5 ml) or medication

  14. Indications for IV • large volume medications; medical emergencies • FLAN and ICG (indocyanine green) • anaphylaxis  IV epinephrine (not used much) • acute angle closure glaucoma  IV mannitol • Rule-out Myasthenia Gravis  IV Tensilon (ice pack test is just as effective, however)

  15. Specifics about IV NaFl • 100 mg/ml (10%): 5 ml administered (most common) • 250 mg/ml (25%): 2 or 3 ml for eyes with opaque media • 80-90% bound to plasma albumin (only 10-20% free to reach eye)

  16. The dark appearance of fovea in FLAN is caused by … • absence of blood vessels in fovealavascular zone • blockage of choroidal fluorescence due to increased density of xanthophyll at the fovea • blockage of choroidal fluorescence by RPE cells at fovea, which are larger and contain more melanin than elsewhere

  17. Phases of FLAN • ophthalmic artery • short posterior ciliary arteries (fill first) • choroidal circulation • central retinal artery • retinal circulation

  18. IV NaFl: contraindications and warnings • history of previous reaction • asthma • recent stroke, myocardial infarction, unstable angina • pregnancy and lactation • radical mastectomy • renal disease

  19. IV NaFl: Milder? adverse reactions • nausea & vomiting • quick & short lived • extravasation (NaFl leaks out of injection site  not in vein; reason why saline is initially injected) • ice packs • dizziness and fainting • pruritis & urticaria (itching & hives)

  20. chalazion management stats • conservative treatment (hot compresses with digital massage) • 40% get better • works well for recent onset chalazion • Intralesional injections alone • 80% • injections + conservative • 90% • incision & curettage • near 100% • ODs do not do this!

  21. chalazion evaluation • how big? • how long? • anterior or posterior to tarsal plate? • injection route  conj side (flip lid) OR skin side. • “Rule of sixes” • chalazion > 6 mm; or • duration > 6 months • may not resolve with injection

  22. intralesionalinejctions: complications • Very safe procedure • Very effective procedure • Very easy to do • MINIMAL complications • pain on injection • depigmentation @ site (caution black patients) • bruising • ptosis • vasovagal syncope (faint)

  23. differentiate internal hordeolum vs. chalazion • PAIN • hordeolum is painful • Recurring chalazion?? • sebaceous cell carcinoma

  24. Local anesthetic Xylocaine • subcutaneous injection prior to various procedures • cyst removal or drainage • papilloma and eyelid lesion removal • incision and curettage of chalazion • MOA’s • Xylocaine reversibly blocks nerve conduction  temporary paralysis of sensory and motor function with loss of sensation • Epinephrine (1:100,000  not same as EPI pen)  vasoconstrictor; prolongs anesthesia  decreases systemic absorption & local bleeding

  25. subconjunctival considerations • delivers increased concentration vs. topicals • prolonged tissue exposure • avoid systemic effects • reduce/eliminate compliance issues

  26. subconjunctival indications • refractory uveitis • methylprednisone or kenalog • cystoid macular edema post-op • NSAIDs: Acular, Nevanac, Voltarin, Xibrom • corneal ulcers • trabeculoctomy

  27. subconjunctival contraindications • known hypersensitivity • steroid responders • infectious etiology if using steroids

More Related